Corrigendum: Modulated TRPC1 Expression Predicts Sensitivity of Breast Cancer to Doxorubicin and Magnetic Field Therapy: Segue Towards a Precision Medicine Approach

Detalles Bibliográficos
Autores principales: Tai, Yee Kit, Chan, Karen Ka Wing, Fong, Charlene Hui Hua, Ramanan, Sharanya, Yap, Jasmine Lye Yee, Yin, Jocelyn Naixin, Yip, Yun Sheng, Tan, Wei Ren, Koh, Angele Pei Fern, Tan, Nguan Soon, Chan, Ching Wan, Huang, Ruby Yun Ju, Li, Jing Ze, Fröhlich, Jürg, Franco-Obregón, Alfredo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9067241/
https://www.ncbi.nlm.nih.gov/pubmed/35515135
http://dx.doi.org/10.3389/fonc.2022.892408

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9067241/
https://www.ncbi.nlm.nih.gov/pubmed/35515135
http://dx.doi.org/10.3389/fonc.2022.892408

Ejemplares similares